the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Epigenetics, Pluripotency, and Reprogramming 2009 Market Report

Published by Select Biosciences, Ltd. Contact us : +1-860-674-8796
Published 2009/05 Content info 139 pages
Product code SB94761
Price From  US $ 2510 Order/Price list
US $ 2510 PDF by E-mail (Single User License)
US $ 2790 PDF by E-mail (Site License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Abstract

This is the latest and most up-to-date Epigenetics, Cellular Reprogramming, and iPSC Market Analysis Report from Select Biosciences. This comprehensive report provides a thorough discussion and analysis of the emerging epigenetics space and cellular reprogramming and the iPSC phenomenon from both a technical as well as market-focused perspective. Qualitative and quantitative analysis of the epigenetics and pluripotency, hESC, iPSC spaces thorough bottom-up based market trends obtained via detailed market surveys administered by Select Biosciences to a worldwide industry participant pool are presented in this report. All report purchasers receive access to all the raw market data collected via online access to our secure server - allows the report purchasers to query the data in different ways to analyze the various market segments.

This Comprehensive Industry Report Addresses the Technical and Market Landscape of Epigenetics, Reprogramming, and Induced Pluripotent Stem Cells (iPSCs): These are Emerging Areas for which Qualitative and Quantitative Analyses are presented

Extensive Worldwide Technical and Market Analyses Presented in this Report:

  • Technical aspects of Epigenetics: The various modifications that constitute epigenetics, their roles in vivo and experimental methods to detect them
  • Genes that are subject to epigenetic modifications in various disease areas (various cancers, CNS diseases)
  • Epigenetics-based therapeutics: Mechanisms of action, preclinical and clinical trials pipelines (for DNA methylation-based therapeutics, HDAC inhibitors)
  • Commercialized epigenetics-based therapeutics
  • Cellular reprogramming, pluripotency, and iPSCs: Technology trends, in vivo mechanism, experimental manipulation, and emerging trends
  • Results and Analyses from Select Biosciences recent worldwide market surveys focusing upon the qualitative and quantitative trends in epigenetics and pluripotency/hESCs/iPSCs. Areas of coverage include the market penetrance of various hESCs used industry-wide, distribution of the industry with respect to types of epigenetic modifications studied, and emerging market trends in epigenetics and the iPSC spaces. All report purchasers also receive access to the raw market data via online access to secure server
  • More details of the scope of coverage of this industry report are found in the table of contents (TOC) for the report - see below for link to downloadable PDF of the TOC
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.